Literature DB >> 15071170

trans-activation of PPARalpha and induction of PPARalpha target genes by perfluorooctane-based chemicals.

Jonathan M Shipley1, Christopher H Hurst, Sue S Tanaka, Fred L DeRoos, John L Butenhoff, Andrew M Seacat, David J Waxman.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are ligand-dependent transcription factors that activate target genes involved in lipid metabolism, energy homeostasis, and cell differentiation in response to diverse compounds, including environmental chemicals. The liver-expressed receptor PPARalpha mediates peroxisome proliferative responses associated with rodent hepatocarcinogenesis. Previous studies have established that certain perfluorooctanesulfonamide-based chemicals (PFOSAs) alter lipid metabolism, are hepatic peroxisome proliferators, and induce hepatocellular adenoma formation in rodents, suggesting that they activate PPARalpha. The present study investigates this question and characterizes the activation of mouse and human PPARalpha by PFOSAs. Perfluorooctanesulfonate (PFOS), an end-stage metabolite common to several PFOSAs, was found to activate both mouse and human PPARalpha in a COS-1 cell-based luciferase reporter trans-activation assay. Half-maximal activation (EC50) occurred at 13-15 microM PFOS, with no significant difference in the responsiveness of mouse and human PPARalpha. Mouse and human PPARalpha were activated by perfluorooctanesulfonamide (FOSA) over a similar concentration range; however, cellular toxicity precluded an accurate determination of EC50 values. Studies of 2-N-ethylperfluorooctanesulfonamido ethanol were less informative due to its insolubility. These findings were verified in an FAO rat hepatoma cell line that stably expresses PPARalpha, where the endogenous PPARalpha target genes peroxisomal bifunctional enzyme and peroxisomal 3-ketoacyl-CoA thiolase were activated up to approximately 10-20-fold by PFOS and FOSA. The interactions of PPARalpha with PFOS and FOSA, and the potential of these chemicals for activation of unique sets of downstream target genes, may help explain the diverse biological effects exhibited by PFOSAs and may aid in the evaluation of human and environmental risks associated with exposure to this important class of fluorochemicals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071170     DOI: 10.1093/toxsci/kfh130

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  30 in total

1.  Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice.

Authors:  Patricia A Fair; Erin Driscoll; Meagan A M Mollenhauer; Sarah G Bradshaw; Se Hun Yun; Kurunthachalam Kannan; Gregory D Bossart; Deborah E Keil; Margie M Peden-Adams
Journal:  J Immunotoxicol       Date:  2011-01-24       Impact factor: 3.000

2.  Perfluorooctane sulfonate increases β-oxidation of palmitic acid in chicken liver.

Authors:  Marcus Nordén; Ola Westman; Nikolaos Venizelos; Magnus Engwall
Journal:  Environ Sci Pollut Res Int       Date:  2012-03-23       Impact factor: 4.223

3.  Paradoxical Protective Effect of Perfluorooctanesulfonic Acid Against High-Fat Diet-Induced Hepatic Steatosis in Mice.

Authors:  Ian Huck; Kevin Beggs; Udayan Apte
Journal:  Int J Toxicol       Date:  2018-08-22       Impact factor: 2.032

4.  Per- and Polyfluoroalkyl Substance Exposure, Gestational Weight Gain, and Postpartum Weight Changes in Project Viva.

Authors:  Susanna D Mitro; Sharon K Sagiv; Sheryl L Rifas-Shiman; Antonia M Calafat; Abby F Fleisch; Lindsay M Jaacks; Paige L Williams; Emily Oken; Tamarra M James-Todd
Journal:  Obesity (Silver Spring)       Date:  2020-10       Impact factor: 5.002

5.  PPAR-α, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression.

Authors:  Vijay R More; Christopher R Campos; Rebecca A Evans; Keith D Oliver; Gary Ny Chan; David S Miller; Ronald E Cannon
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

6.  Gene Expression Profiling in Wild-Type and PPARα-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARα-Independent Effects.

Authors:  Mitchell B Rosen; Judith R Schmid; J Christopher Corton; Robert D Zehr; Kaberi P Das; Barbara D Abbott; Christopher Lau
Journal:  PPAR Res       Date:  2010-09-27       Impact factor: 4.964

7.  In vitro evaluation of the effects of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) on IL-2 production in human T-cells.

Authors:  Kristin Midgett; Margie M Peden-Adams; Gary S Gilkeson; Diane L Kamen
Journal:  J Appl Toxicol       Date:  2014-07-23       Impact factor: 3.446

Review 8.  Minireview: the case for obesogens.

Authors:  Felix Grün; Bruce Blumberg
Journal:  Mol Endocrinol       Date:  2009-04-16

9.  The induction of atherogenic dyslipidaemia in poloxamer 407-treated mice is not mediated through PPARalpha.

Authors:  Thomas P Johnston; David J Waxman
Journal:  J Pharm Pharmacol       Date:  2008-06       Impact factor: 3.765

10.  Binding of PFOS to serum albumin and DNA: insight into the molecular toxicity of perfluorochemicals.

Authors:  Xian Zhang; Ling Chen; Xun-Chang Fei; Yin-Sheng Ma; Hong-Wen Gao
Journal:  BMC Mol Biol       Date:  2009-02-25       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.